Nkemngu Njinkeng J, Asonganyi Etienne D N, Njunda Anna L
St. John's Maternity and Hospital, Fiango, Kumba, Cameroon.
BMC Infect Dis. 2005 Jun 21;5:49. doi: 10.1186/1471-2334-5-49.
Fluoroquinolones or third generation cephalosporins are the drugs of choice for the treatment of typhoid fever. Treatment failure with fluoroquinolones has been reported in Asia and Europe. We report a case of ciprofloxacin treatment failure in typhoid fever in Cameroon.
A 29-year-old female patient with suspected typhoid fever from Kumba, Cameroon, yielded growth of Salmonella enterica serovar Typhi in blood culture. The isolate was resistant to nalidixic acid but sensitive to ciprofloxacin by disc diffusion test. However, the patient did not respond to treatment with ciprofloxacin, although the isolate was apparently susceptible to ciprofloxacin.
Treatment failure with ciprofloxacin in our case indicates the presence of nalidixic acid resistant S. enterica serovar Typhi (NARST) with reduced susceptibility to ciprofloxacin in Cameroon (Central Africa).
氟喹诺酮类药物或第三代头孢菌素是治疗伤寒热的首选药物。在亚洲和欧洲,已有氟喹诺酮类药物治疗失败的报道。我们报告了喀麦隆一例伤寒热患者使用环丙沙星治疗失败的病例。
一名来自喀麦隆昆巴的29岁疑似伤寒热女性患者,血培养分离出肠炎沙门氏菌伤寒血清型。通过纸片扩散试验,该分离株对萘啶酸耐药,但对环丙沙星敏感。然而,尽管该分离株显然对环丙沙星敏感,但患者对环丙沙星治疗无反应。
我们病例中环丙沙星治疗失败表明喀麦隆(中非)存在对萘啶酸耐药且对环丙沙星敏感性降低的肠炎沙门氏菌伤寒血清型(NARST)。